YKP 581
Alternative Names: YKP581Latest Information Update: 10 Jul 2009
At a glance
- Originator Johnson & Johnson; SK Bio-Pharmaceuticals
- Developer Johnson & Johnson; SK Drug Development Center
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 11 Oct 2005 Phase-I clinical trials in Depression in Europe (unspecified route)